首页> 外文期刊>Journal of thrombosis and haemostasis: JTH >Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study
【24h】

Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study

机译:一项基于人群的前瞻性研究显示,游离甲状腺素水平升高和静脉血栓形成的风险

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Recent studies have shown that high levels of free thyroxine (FT4), even without leading to hyperthyroidism, are associated with a procoagulant state. Objectives: The aim of our study was to determine whether high levels of thyroid hormones are associated with an increased risk of venous thrombosis. Patients/Methods: From a prospective nested case-cohort design within the second Nord-Tr?ndelag Health Study (HUNT2) cohort (1995-1997; 66140 subjects), all patients with venous thrombosis during follow-up (n=515) and 1476 randomly selected age-stratified and sex-stratified controls were included. Relative and absolute risks for venous thrombosis were calculated for different cut-off levels of thyroid hormones on the basis of percentiles in the controls and different times between blood sampling and thombosis. Results: In subjects with an FT4 level above the 98th percentile (17.3pmolL -1), the odds ratio (OR) was 2.5 (95% confidence interval [CI] 1.3-5.0) as compared with subjects with levels below this percentile. For venous thrombosis within 1 year from blood sampling, this relative risk was more pronounced, with an OR of 4.8 (95% CI 1.7-14.0). Within 0.5 years, the association was even stronger, with an OR of 9.9 (95% CI 2.9-34.0, adjusted for age, sex, and body mass index). For thyroid-stimulating hormone, the relationship was inverse and less pronounced. The absolute risk within 6 months in the population for FT4 levels above the 98th percentile was 6.1 per 1000 person-years (95% CI 1.7-15.7). Conclusions: Levels of FT4 at the upper end of the normal range are a strong risk factor for venous thrombosis. The risk increased with higher levels of thyroxine and shorter time between blood sampling and thrombosis. Further studies on the effect of clinical hyperthyroidism are warranted.
机译:背景:最近的研究表明,即使不导致甲状腺功能亢进,高水平的游离甲状腺素(FT4)也与促凝状态有关。目的:我们的研究目的是确定高水平的甲状腺激素是否与静脉血栓形成的风险增加有关。患者/方法:根据第二次Nord-Tr?ndelag健康研究(HUNT2)队列(1995-1997; 66140名受试者)中的前瞻性嵌套病例队列设计,所有患者在随访期间均发生静脉血栓形成(n = 515),并且包括1476个随机选择的按年龄分层和按性别分层的对照。根据对照中的百分位数和采血与血栓形成之间的不同时间,针对不同的甲状腺激素截断水平,计算出静脉血栓形成的相对和绝对风险。结果:在FT4水平高于第98个百分点(17.3pmolL -1)的受试者中,比水平低于该百分比的受试者的优势比(OR)为2.5(95%置信区间[CI] 1.3-5.0)。对于采血后1年内的静脉血栓形成,这种相对风险更为明显,OR为4.8(95%CI 1.7-14.0)。在0.5年内,关联性甚至更高,OR值为9.9(95%CI 2.9-34.0,根据年龄,性别和体重指数进行调整)。对于促甲状腺激素,这种关系是相反的,并且不那么明显。 FT4水平高于98%百分数的人群在6个月内的绝对风险是每千人年6.1(95%CI 1.7-15.7)。结论:正常范围上限的FT4水平是静脉血栓形成的重要危险因素。甲状腺素水平越高,血液采样和血栓形成之间的时间越短,风险就越大。临床上甲亢的影响有待进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号